Published in IJCP
ESICON 2018: 48th Annual Conference of Endocrine Society of India
March 11, 2019 | ESICON 2018
The CANVAS Program integrated data from two trials with a total of 10,142 participants with type 2 diabetes and high cardiovascular (CV) risk. The primary outcome was a composite of death from CV causes, nonfatal myocardial infarction (MI) or nonfatal stroke.